280 related articles for article (PubMed ID: 8566596)
1. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.
Babyatsky MW; deBeaumont M; Thim L; Podolsky DK
Gastroenterology; 1996 Feb; 110(2):489-97. PubMed ID: 8566596
[TBL] [Abstract][Full Text] [Related]
2. Topical and intravenous administration of trefoil factors protect the gastric mucosa from ethanol-induced injury in the rat.
McKenzie C; Thim L; Parsons ME
Aliment Pharmacol Ther; 2000 Aug; 14(8):1033-40. PubMed ID: 10930897
[TBL] [Abstract][Full Text] [Related]
3. Trefoil peptides: a novel modality to prevent gastric injury?
Rachmilewitz D
Gastroenterology; 1996 Feb; 110(2):632-5. PubMed ID: 8566614
[No Abstract] [Full Text] [Related]
4. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat.
Chinery R; Playford RJ
Clin Sci (Lond); 1995 Apr; 88(4):401-3. PubMed ID: 7789040
[TBL] [Abstract][Full Text] [Related]
5. Molecular aspects of restitution: functions of trefoil peptides.
Poulsom R; Begos DE; Modlin IM
Yale J Biol Med; 1996; 69(2):137-46. PubMed ID: 9112745
[TBL] [Abstract][Full Text] [Related]
6. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium.
Taupin D; Pedersen J; Familari M; Cook G; Yeomans N; Giraud AS
Lab Invest; 2001 Mar; 81(3):397-408. PubMed ID: 11310832
[TBL] [Abstract][Full Text] [Related]
7. Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats.
Cook GA; Thim L; Yeomans ND; Giraud AS
J Gastroenterol Hepatol; 1998 Apr; 13(4):363-70. PubMed ID: 9641298
[TBL] [Abstract][Full Text] [Related]
8. [Effect of recombinant human trefoil factor on protection of gastric mucosa and healing of chronic gastric ulcer in rats].
Dong X; Zhou L; Lin S; Ru B; Fang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):639-41. PubMed ID: 14710261
[TBL] [Abstract][Full Text] [Related]
9. Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulceration.
Cook GA; Yeomans ND; Giraud AS
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1540-9. PubMed ID: 9227492
[TBL] [Abstract][Full Text] [Related]
10. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury.
Farrell JJ; Taupin D; Koh TJ; Chen D; Zhao CM; Podolsky DK; Wang TC
J Clin Invest; 2002 Jan; 109(2):193-204. PubMed ID: 11805131
[TBL] [Abstract][Full Text] [Related]
11. Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells.
Andoh A; Kinoshita K; Rosenberg I; Podolsky DK
J Immunol; 2001 Oct; 167(7):3887-93. PubMed ID: 11564806
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility.
McKenzie C; Marchbank T; Playford RJ; Otto W; Thim L; Parsons ME
Am J Physiol; 1997 Jul; 273(1 Pt 1):G112-7. PubMed ID: 9252516
[TBL] [Abstract][Full Text] [Related]
13. Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro.
Tanaka S; Podolsky DK; Engel E; Guth PH; Kaunitz JD
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1473-80. PubMed ID: 9227484
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat.
Poulsen SS; Thulesen J; Christensen L; Nexo E; Thim L
Gut; 1999 Oct; 45(4):516-22. PubMed ID: 10486358
[TBL] [Abstract][Full Text] [Related]
15. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis.
Tran CP; Cook GA; Yeomans ND; Thim L; Giraud AS
Gut; 1999 May; 44(5):636-42. PubMed ID: 10205199
[TBL] [Abstract][Full Text] [Related]
16. The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut.
Taupin DR; Pang KC; Green SP; Giraud AS
Peptides; 1995; 16(6):1001-5. PubMed ID: 8532580
[TBL] [Abstract][Full Text] [Related]
17. Trefoil peptides: mitogens, motogens, or mirages?
Modlin IM; Poulsom R
J Clin Gastroenterol; 1997; 25 Suppl 1():S94-100. PubMed ID: 9479633
[TBL] [Abstract][Full Text] [Related]
18. Trefoil peptides: what are they and what do they do?
Playford RJ
J R Coll Physicians Lond; 1997; 31(1):37-41. PubMed ID: 9044196
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting.
Tan XD; Hsueh W; Chang H; Wei KR; Gonzalez-Crussi F
Biochem Biophys Res Commun; 1997 Aug; 237(3):673-7. PubMed ID: 9299425
[TBL] [Abstract][Full Text] [Related]
20. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis.
Taupin DR; Kinoshita K; Podolsky DK
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):799-804. PubMed ID: 10639160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
